AMLX R&D Expenses
Amylyx Pharmaceuticals Inc · R&D Expenses
AMLX R&D Expenses
Latest reported$92.34Mperiod ending
AMLX R&D Expenses ($11.90M → $92.34M)
Annual R&D Expenses
High-resolution chart · PNG
AMLX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 90,404,000 | |
| 104,084,000 | |
| 128,187,000 | |
| 93,450,000 | |
| 44,040,000 | |
| 24,594,000 | |
| 11,899,000 |